Patent ID: 8577478
Filing Date: 2013-11-05
Classification: A61B,A61F,A61N,F04C

Abstract:
1. A sleep apnea treatment device, comprising: a primary antenna configured to be located external to a subject, at least one processor in electrical communication with the primary antenna, the at least one processor configured to: cause transmission of a primary signal from the primary antenna to an implantable device implanted in the subject on a genioglossus muscle proximal to a hypoglossal nerve of the subject, wherein the implantable device includes at least one pair of modulation electrodes, wherein the processor is further configured to adjust one or more characteristics of the primary signal to generate a sub-modulation control signal adapted to cause a current at the at least one pair of modulation electrodes below a neuromuscular modulation threshold of the hypoglossal nerve when received by the implantable device and to generate a modulation control signal adapted to cause a current at the at least one pair of modulation electrodes above a neuromuscular modulation threshold of the hypoglossal nerve when received by the implantable device.